Minna Heeraman had an aggressive cancer. Did the March 2020 treatment shutdown shorten her life?
Minna ’s pancreatic surgery was cancelled as a result of the pandemic. By the time treatments resumed, her tumour was too big for doctors to operateWhen Minna Heeraman ’s friends knew that she was dying, they made a video for her to watch from the hospital bed she had set up in her living room. It was a goodbye video. One after another, her friends spoke to the camera with tears in their eyes. They shared their memories of times spent together. Wine in the garde n on sunny afternoons. Hen dos. Weddings. Christmas meet-ups. “I don’t know what more to say, Minna,” says one friend, choking back s...
Source: Guardian Unlimited Science - May 4, 2021 Category: Science Authors: Sirin Kale Tags: Cancer Society Coronavirus Infectious diseases Medical research Science NHS Health Source Type: news

St. Louis-born Galera's stock soars after release of positive study data for its experimental cancer therapy
Galera Therapeutics' stock price jumped 41% Thursday morning after the St. Louis-born biopharmaceutical company provided updated results from early-stage testing of its experimental therapy for advanced pancreatic cancer. The company's stock began trading Thursday at $9.34 per share after closing Wednesday at $6.61. (Galera's stock simmered down later, closing Thursday at $8.12 a share and opening Friday morning at $7.89.) Galera (NASDAQ: GRTX) is developing proprietary therapies that have the… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - April 30, 2021 Category: Health Management Authors: John George Source Type: news

St. Louis-born Galera's stock soars after release of positive study data for its experimental cancer therapy
Galera Therapeutics' stock price jumped 41% Thursday morning after the St. Louis-born biopharmaceutical company provided updated results from early-stage testing of its experimental therapy for advanced pancreatic cancer. The company's stock began trading Thursday at $9.34 per share after closing Wednesday at $6.61. (Galera's stock simmered down later, closing Thursday at $8.12 a share and opening Friday morning at $7.89.) Galera (NASDAQ: GRTX) is developing proprietary therapies that have the… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 30, 2021 Category: Biotechnology Authors: John George Source Type: news

Isotopia backs development of 'virtual' biopsy
Isotopia Molecular Imaging has announced it is backing research led by Israel...Read more on AuntMinnie.comRelated Reading: Isotopia to supply MTTI with Lu-177 ARTMS, Isotopia produce PSMA-11 in cyclotron Isotopia partners with Y-mAbs on radioisotope Isotopia, CPDC ink manufacturing deal for lutetium-177 Virtual biopsy accurately diagnoses pancreatic cysts (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 29, 2021 Category: Radiology Source Type: news

Ludwig Cancer Research study shows pancreatic cancer cells reverse to advance malignancy
(Ludwig Institute for Cancer Research) A Ludwig Cancer Research study has identified a previously unrecognized mechanism by which cancer cells of a relatively benign subtype of pancreatic tumors methodically revert--or " de-differentiate " --to a progenitor, or immature, state of cellular development to spawn highly aggressive tumors that are capable of metastasis to the liver and lymph nodes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 28, 2021 Category: International Medicine & Public Health Source Type: news

Scientists create first-of-its-kind 3D organoid model of the human pancreas
(Beth Israel Deaconess Medical Center) Researchers have successfully created the first three-dimensional (3D) organoid models of the pancreas from human stem cells. This first-of-its-kind organoid model includes both the acinar and ductal structures that play a critical role in the majority of pancreatic cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 28, 2021 Category: Cancer & Oncology Source Type: news

Do Blood Tests Show Pancreatic Cancer?
Title: Do Blood Tests Show Pancreatic Cancer?Category: Diseases and ConditionsCreated: 4/27/2021 12:00:00 AMLast Editorial Review: 4/27/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 27, 2021 Category: Cancer & Oncology Source Type: news

Ian Gibson obituary
Cancer researcher who sought to make the public case for science as a Labour MPIan Gibson, who has died aged 82 of pancreatic cancer, had a considerable reputation as a cancer researcher before seeking a political career in order to try to advance the cause of science in public life. He was elected for the first time in 1997, aged 58, as the Labour MP for Norwich North and spent the ensuing 12 years in an energetic pursuit of this case, while also propounding his strongly held convictions on a wide range of issues about health and education.He was a popular, charismatic man who won the influential chairmanship of the Commo...
Source: Guardian Unlimited Science - April 25, 2021 Category: Science Authors: Julia Langdon Tags: Labour Politics past People in science Medical research Norwich UK news Source Type: news

Margin - Positive Surgery Still Beneficial in Pancreatic Cancer
Survival benefit seen for surgery, even with R1/R2 resection margins compared with chemotherapy alone for stage II pancreatic cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 22, 2021 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Surgery, Journal, Source Type: news

Margin-Positive Surgery Still Beneficial in Pancreatic Cancer
THURSDAY, April 22, 2021 -- For patients with stage II pancreatic cancer, attempted surgery with margin-positive resection may offer survival benefit over chemotherapy alone, according to a study published online March 26 in the Journal of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 22, 2021 Category: Pharmaceuticals Source Type: news

Pleural Mesothelioma Patients with 5-Year Survival Still Rare
Although no amount of asbestos exposure is considered safe, lower levels of non-occupational exposure are most often linked to long-term survival for those diagnosed with malignant pleural mesothelioma, according to a recent study. Clinical Lung Cancer published the study that compared characteristics of 43 pleural mesothelioma patients who survived at least five years with the disease to a much larger control group. Several previous mesothelioma studies have estimated that the five-year survival rate is just under 5% for pleural mesothelioma, an aggressive cancer with no definitive cure. It is caused almost exclusiv...
Source: Asbestos and Mesothelioma News - April 22, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Improving survival in pancreatic cancer
(Nagoya University) Nagoya University researchers and colleagues have uncovered a molecular pathway that enhances chemotherapy resistance in some pancreatic cancer patients. Targeting an RNA to interrupt its activity could improve patient response to therapy and increase their overall survival. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 22, 2021 Category: International Medicine & Public Health Source Type: news

Is Pancreatic Cancer Back Pain Constant?
Title: Is Pancreatic Cancer Back Pain Constant?Category: Diseases and ConditionsCreated: 4/21/2021 12:00:00 AMLast Editorial Review: 4/21/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 21, 2021 Category: Cancer & Oncology Source Type: news

Cousin Itt from 'Addams Family,' Felix Silla Dead at 84
'The Addams Family' star Felix Silla died after a battle with pancreatic cancer. (Source: Reuters: Health)
Source: Reuters: Health - April 17, 2021 Category: Consumer Health News Source Type: news

Felix Silla Dies: Cousin Itt On TV ’s ‘The ‘Addams Family’ Was 84
Felix Silla, best known as the gibberish-spouting Cousin Itt on the 1960s TV sitcom The Addams Family, died today from pancreatic... (Source: Reuters: Health)
Source: Reuters: Health - April 16, 2021 Category: Consumer Health News Source Type: news

Pancreatic Cancer Surveillance in High-Risk: No Better Outcomes Pancreatic Cancer Surveillance in High-Risk: No Better Outcomes
Surveillance of people at high hereditary risk for pancreatic ductal adenocarcinoma can lead to diagnosis at an earlier stage, but as yet there is no clear survival benefit, a new study suggests.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - April 16, 2021 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Symptoms of Exocrine Pancreatic Insufficiency
What Are the Symptoms of Exocrine Pancreatic Insufficiency? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 16, 2021 Category: General Medicine Source Type: news

Research sheds new light on pancreatic cancer metastasis
(University of Oklahoma) A team of researchers at the OU College of Medicine has published a new study in the journal Gastroenterology, the world's leading publication on GI tract disease, that sheds new light on the ability of pancreatic cancer cells to spread throughout the body. Understanding why metastasis occurs is crucial for developing a therapeutic strategy to stop the spread. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 16, 2021 Category: Cancer & Oncology Source Type: news

Potential ways to improve survival for cancer patients who receive fragmented care
(American College of Surgeons) New research reveals that 28 percent of patients who are readmitted to the hospital with complications after surgical removal of pancreatic, liver, or stomach cancer go to a different hospital for follow-up care. This fragmentation of health care is associated with a 50 percent increased odds of dying, according to a study published online by the Journal of the American College of Surgeons ahead of print. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 15, 2021 Category: Cancer & Oncology Source Type: news

Is Pancreatic Insufficiency Curable
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 14, 2021 Category: General Medicine Source Type: news

Dannielle Engle awarded prestigious pancreatic cancer research grant
(Salk Institute) Salk Assistant Professor Dannielle Engle was selected as the first recipient of the Lustgarten Foundation-AACR Career Development Award for Pancreatic Cancer Research in Honor of Ruth Bader Ginsburg, the late Supreme Court Justice and women's rights pioneer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 14, 2021 Category: Cancer & Oncology Source Type: news

Eckert & Ziegler secures technetium licenses for Brazil
Isotope technology firm Eckert & Ziegler has secured a license to marke...Read more on AuntMinnie.comRelated Reading: Eckert & Ziegler breaks ground on U.S. facility Isotopia, Eckert & Ziegler partner Eckert & Ziegler to open U.S. isotope facility Eckert & Ziegler reports loss in Q4 Eckert & Ziegler to produce pancreatic cancer agent (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 12, 2021 Category: Radiology Source Type: news

Mutant KRAS and p53 cooperate to drive pancreatic cancer metastasis
(University of Texas M. D. Anderson Cancer Center) MD Anderson researchers have discovered that mutant KRAS and p53, the most frequently mutated genes in pancreatic cancer, interact to promote metastasis and tumor growth. The findings point to a new therapeutic target for this deadly cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 10, 2021 Category: Cancer & Oncology Source Type: news

Immune-stimulating drug before surgery shows promise in early-stage pancreatic cancer
(University of Pennsylvania School of Medicine) Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack to the notoriously stubborn tumor microenvironment before surgery and other treatments, according to a new study from researchers in the Abramson Cancer Center at the University of Pennsylvania. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 10, 2021 Category: International Medicine & Public Health Source Type: news

MD Anderson and TriSalus Life Sciences announce strategic research collaboration to evaluate treatment of solid tumors
(University of Texas M. D. Anderson Cancer Center) MD Anderson and TriSalus announced a strategic research collaboration to evaluate the treatment of liver and pancreas tumors with the investigational therapy SD-101 in combination with immunotherapy using a novel delivery approach. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 8, 2021 Category: International Medicine & Public Health Source Type: news

Surgery Can Boost Outcomes After Chemo for People With Pancreatic Cancer
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 31, 2021 Category: Cancer & Oncology Tags: Family Medicine, Oncology, Surgery, News, Source Type: news

Surgery Can Boost Outcomes After Chemo for People With Pancreatic Cancer
WEDNESDAY, March 31, 2021 -- Even in patients with stage 2 pancreatic cancer, surgery is typically worthwhile after chemotherapy, because it appears to extend patients'lives, a new study concludes. In stage 2 cancer, the tumor has already grown... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 31, 2021 Category: General Medicine Source Type: news

Surgery Can Boost Outcomes After Chemo for People With Pancreatic Cancer
Title: Surgery Can Boost Outcomes After Chemo for People With Pancreatic CancerCategory: Health NewsCreated: 3/31/2021 12:00:00 AMLast Editorial Review: 3/31/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - March 31, 2021 Category: Cancer & Oncology Source Type: news

Bluestar Genomics gains FDA Breakthrough Device designation for pancreatic can
(EAG Advertising& Marketing) Bluestar Genomics announces today it received U.S. Food and Drug Administration (FDA) Breakthrough Device designation for its proprietary noninvasive pancreatic cancer detection test in patients with new-onset diabetes. The FDA's Breakthrough Device program accelerates the development of medical devices that have the potential to effectively treat or diagnose life-threatening or irreversibly debilitating diseases. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 31, 2021 Category: Biology Source Type: news

New clinical trial studies pancreatic cancer tumor traits to uncover better treatments
(Stand Up To Cancer) A new team of pioneering pancreatic cancer researchers has been formed to predict which treatments might work best for individual pancreatic cancer patients based on the molecular traits of tumors. The Pancreatic Cancer Convergence Dream Team is funded by the Pancreatic Cancer Collective, an initiative of the Lustgarten Foundation and Stand Up To Cancer ® (SU2C), SU2C Canada and Pancreatic Cancer Canada. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 30, 2021 Category: Cancer & Oncology Source Type: news

Getting a Prescription to Die Remains Tricky Even As Aid-in-Dying Bills Gain Momentum Across the U.S.
Linda Heim knew her dad didn’t plan to wait for the cancer to kill him. For decades, he’d lived in Montana, which they’d thought was one of the few places where terminally ill people could get a prescription to end their life. After two years of being sick, Heim’s dad got the diagnosis in 2019: stage 4 kidney cancer. His physician offered treatments that might extend his life by months. Instead, the 81-year-old asked the doctor for help dying. Heim said her parents left the appointment in their hometown of Billings with two takeaways: The legality of medically assisted death was questionable in Mont...
Source: TIME: Health - March 29, 2021 Category: Consumer Health News Authors: Katheryn Houghton / Kaiser Health News Tags: Uncategorized COVID-19 Source Type: news

Surgery is a viable treatment for pancreatic cancer patients especially after chemotherapy
(American College of Surgeons) Patients with stage II pancreatic cancer who are treated with chemotherapy followed by resection (an operation that removes the cancerous part of the organ, structure or tissue) live nearly twice as long as patients who receive only chemotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 26, 2021 Category: Cancer & Oncology Source Type: news

UCLA researchers receive $6 million from NIH to explore new pancreatic cancer therapies
A team of researchers from theUCLA Jonsson Comprehensive Cancer Center has been awarded two research grants totaling $6 million from the National Institutes of Health to identify new ways to treat pancreatic cancer.Pancreatic cancer is the third leading cause of cancer-related mortality in the United States, accounting for more than 47,000 deaths annually. Only 1 in 10 people diagnosed with this particularly aggressive disease live beyond five years, and most therapies — including conventional chemotherapies, targeted therapies and immunotherapies — are unsuccessful in treating it.“Pancreatic cancer is on...
Source: UCLA Newsroom: Health Sciences - March 25, 2021 Category: Universities & Medical Training Source Type: news

UCLA team receives $6 million from NIH to explore new pancreatic cancer therapies
(University of California - Los Angeles Health Sciences) A team of researchers from the UCLA Jonsson Comprehensive Cancer Center has been awarded two research grants totaling $6 million from the National Institutes of Health to identify new ways to treat pancreatic cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 25, 2021 Category: Cancer & Oncology Source Type: news

Decades of radiation-based scientific theory disproven by Ben-Gurion University US-based study
(American Associates, Ben-Gurion University of the Negev) According to the study, lower levels of several types of cancers were found when the radiation levels were on the higher end of the spectrum rather than on the lower end. Among both men and women, there was a significant decrease in lung, pancreatic, colon and rectal cancers. Among men, there were additional decreases in brain and bladder cancers. There was no decrease in cervix, breast or prostate cancers or leukemia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 24, 2021 Category: International Medicine & Public Health Source Type: news

Why 2020 was the year of marvellous medicine
A vaccine that could treat multiple types of tumours and stop the cancer from returning has been created in Australia. It could be used against breast, lung, ovarian, kidney and pancreatic cancers. (Source: the Mail online | Health)
Source: the Mail online | Health - March 23, 2021 Category: Consumer Health News Source Type: news

Pancreatic cancer symptoms: Five visual warning signs in your poo - 'grey and oily'
PANCREATIC cancer may not have any symptoms, or they might be hard to spot. When they do arise, you may notice a number of changes in your poo. (Source: Daily Express - Health)
Source: Daily Express - Health - March 22, 2021 Category: Consumer Health News Source Type: news

Ablative Radiation Extends Life in Unresectable Pancreatic Cancer Ablative Radiation Extends Life in Unresectable Pancreatic Cancer
Increasing the radiation dose by making adjustments for respiratory and gastrointestinal functions improves the outcome, when given with induction chemotherapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 19, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Pancreatic cancer symptoms: Difficulty flushing poo could be a warning sign
PANCREATIC cancer is deadly - it "has the lowest survival of all common cancers", warned the charity Pancreatic Cancer UK. This is why it's crucial to get treatment as soon as possible. (Source: Daily Express - Health)
Source: Daily Express - Health - March 19, 2021 Category: Consumer Health News Source Type: news

Reversing cancer's gluttony
(University of California - San Diego) Researchers at UC San Diego School of Medicine and Moores Cancer Center describe how pancreatic cancer cells use an alternative method to find necessary nutrients, defying current therapies, to help them grow and spread. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 18, 2021 Category: International Medicine & Public Health Source Type: news

Scientists shrink pancreatic tumors by starving their cellular 'neighbors'
(Sanford Burnham Prebys Medical Discovery Institute) Scientists at Sanford Burnham Prebys Medical Discovery Institute demonstrated for the first time that blocking " cell drinking, " or macropinocytosis, in the thick tissue surrounding a pancreatic tumor slowed tumor growth--providing more evidence that macropinocytosis is a driver of pancreatic cancer growth and is an important therapeutic target. The study was published in Cancer Discovery, a journal of the American Association for Cancer Research. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 17, 2021 Category: Cancer & Oncology Source Type: news

When will PET/MRI live up to its promise?
From its early days 10 years ago to the present, PET/MRI has developed fro...Read more on AuntMinnie.comRelated Reading: FDG-PET/MRI offers option for pediatric Hodgkin lymphoma PET/MRI, CT predict pancreatic cancer treatment response Use F-18 fluciclovine PET/MRI to stage prostate cancer PET/MRI boosts cancer detection PET/MRI ups lesion detection by 15% for some cancers (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 16, 2021 Category: Radiology Source Type: news

A ligand-receptor interactome platform for discovery of pain mechanisms and therapeutic targets
In the peripheral nervous system, ligand-receptor interactions between cells and neurons shape sensory experience, including pain. We set out to identify the potential interactions between sensory neurons and peripheral cell types implicated in disease-associated pain. Using mouse and human RNA sequencing datasets and computational analysis, we created interactome maps between dorsal root ganglion (DRG) sensory neurons and an array of normal cell types, as well as colitis-associated glial cells, rheumatoid arthritis–associated synovial macrophages, and pancreatic tumor tissue. These maps revealed a common correlation...
Source: Signal Transduction Knowledge Environment - March 16, 2021 Category: Science Authors: Wangzhou, A., Paige, C., Neerukonda, S. V., Naik, D. K., Kume, M., David, E. T., Dussor, G., Ray, P. R., Price, T. J. Tags: STKE Research Resources Source Type: news

Curiosity or underdiagnosed? Injuries to thoracolumbar spine with concomitant trauma to pancreas - Hax J, Halvachizadeh S, Jensen KO, Berk T, Teuber H, Di Primio T, Lefering R, Pape HC, Sprengel K, Dgu TR.
The pancreas is at risk of damage as a consequence of thoracolumbar spine injury. However, there are no studies providing prevalence data to support this assumption. Data from European hospitals documented in the TraumaRegister DGU( ®) (TR-DGU) between 200... (Source: SafetyLit)
Source: SafetyLit - March 12, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

AI reduces FDG dose on PET imaging
An artificial intelligence (AI) algorithm can process F-18 FDG PET exams acquire...Read more on AuntMinnie.comRelated Reading: FDG-PET/MRI offers option for pediatric Hodgkin lymphoma FDG-PET/CT shows COVID-19 vaccine uptake Radiomics, AI can guide NSCLC treatment decisions PET/CT guidance offers valuable approach to lung biopsies PET/MRI, CT predict pancreatic cancer treatment response (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 12, 2021 Category: Radiology Source Type: news

Researchers to 3D-print living human pancreas for diabetes research
(Natural News) An international team of researchers will be 3D printing live human pancreas models as part of a research initiative called the “European ENLIGHT Project.” The researchers plan to use the “bioprinted” models to improve the testing of diabetes medications and eventually treatments for other diseases like cancer. The European Union‘s Horizon 2020 Innovation Fund awarded... (Source: NaturalNews.com)
Source: NaturalNews.com - March 10, 2021 Category: Consumer Health News Source Type: news

Therapy sneaks into hard layer of pancreatic cancer tumor and destroys it from within
(University of California - San Diego) Researchers at University of California San Diego School of Medicine and Moores Cancer Center demonstrated that a new tumor-penetrating therapy could enhance the effects of chemotherapy, reduce the spread of pancreatic cancer and increase survival in animal models. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 9, 2021 Category: Biology Source Type: news

Pancreatic cancer: Light coloured stools or dark coloured urine could indicate your risk
PANCREATIC cancer is the 10th most common cancer in the UK with warning signs of your risk found in the colour of your stools and urine. What else should you look out for? (Source: Daily Express - Health)
Source: Daily Express - Health - March 5, 2021 Category: Consumer Health News Source Type: news

Collagen plays protective role during pancreatic cancer development
(University of Texas M. D. Anderson Cancer Center) Contrary to long-held beliefs, new research finds that collagen in the tumor microenvironment does not promote cancer development but plays a protective role in controlling pancreatic cancer growth. The new findings could have important therapeutic implications. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 4, 2021 Category: Cancer & Oncology Source Type: news

PET/MRI biomarkers guide personalized treatment for patients with pancreatic cancer
Positron emission tomography (PET)/MRI has changed how Mayo Clinic specialists treat patients with pancreatic cancer. Mayo Clinic pioneered the use of PET/MRI to manage pancreatic cancer. Now a new study by Ananya Panda, M.B.B.S., and colleagues systematically evaluates the strengths of PET/MRI for pancreatic ductal adenocarcinoma (PDAC). In less than five years, Mayo's PET/MRI practice [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 4, 2021 Category: Databases & Libraries Source Type: news